SeHCAT
| Names | |
|---|---|
| IUPAC name
(75Se)-2-[[[[(3α,5α,7α,12α,20S)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno]acetyl]amino]ethanesulfonic acid,
| |
| Other names
23-Seleno-25-homo-tauro-cholic acid; Selenium homocholic acid taurine; Tauroselcholic acid
| |
| Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
InChI
| |
SMILES
| |
| Properties | |
Chemical formula
|
C26H45NO7SSe |
| Molar mass | 594.68 g·mol−1 |
| Pharmacology | |
| V09DX01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
SeHCAT (23-seleno-25-homotaurocholic acid, selenium homocholic acid taurine, or tauroselcholic acid) is a drug used in a clinical test to diagnose bile acid malabsorption.[1]
- ^ "23-seleno-25-homotaurocholic acid - Compound Summary". CID 123829. NCBI. Retrieved 3 April 2011.